Fahad A. Alhumaydhi

Prof. Fahad A. Alhumaydhi

Medical Laboratories, Qassim University, Buraydah, Al Qaşīm, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Journal of King Saud University – Science
Verified
Journal Article
Open access
SMSaikat Mitra
Saikat Mitra
ACArka Jyoti Chakraborty
Arka Jyoti Chakraborty
Abu Montakim TareqAbu Montakim Tareq
Abu Montakim Tareq
TETalha Bin Emran
Talha Bin Emran
FNFirzan Nainu
Firzan Nainu
Jesus Simal-GandaraJesus Simal-Gandara
Jesus Simal-Gandara

9 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SASaleh Almatroodi
Saleh Almatroodi
AAAhmad Almatroudi
Ahmad Almatroudi
AKAmjad Khan
Amjad Khan
Fahad A. AlhumaydhiFahad A. Alhumaydhi
Fahad A. Alhumaydhi
MAMohammed A. Alsahli
Mohammed A. Alsahli
ARArshad Husain Rahmani
Arshad Husain Rahmani
Epigallocatechin-3-gallate (EGCG), an active compound of green tea and its role in diseases cure and prevention has been proven. Its role in diseases management can be attributed to its antioxidant and anti-inflammatory properties. The anti-cancer role of this green tea compound has been confirmed in various types of cancer and is still being under explored. EGCG has been proven to possess a chemopreventive effect through inhibition of carcinogenesis process such as initiation, promotion, and progression. In addition, this catechin has proven its role in cancer management through modulating various cell signaling pathways such as regulating proliferation, apoptosis, angiogenesis and killing of various types of cancer cells. The additive or synergistic effect of epigallocatechin with chemopreventive agents has been verified as it reduces the toxicities and enhances the anti-cancerous effects. Despite its effectiveness and safety, the implications of EGCG in cancer prevention is certainly still discussed due to a poor bioavailability. Several studies have shown the ability to overcome poor bioavailability through nanotechnology-based strategies such as encapsulation, liposome, micelles, nanoparticles and various other formulation. In this review, we encapsulate therapeutic implication of EGCG in cancer management and the mechanisms of action are discussed with an emphasis on human clinical trials.

4 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Abdur RaufAbdur Rauf
Abdur Rauf
TATareq Abu-Izneid
Tareq Abu-Izneid
AKAnees Ahmed Khalil
Anees Ahmed Khalil
MIMuhammad Imran
Muhammad Imran
ZSZafar Ali Shah
Zafar Ali Shah
TGTanweer Aslam Gondal
Tanweer Aslam Gondal
Berberine (BBR), a potential bioactive agent, has remarkable health benefits. A substantial amount of research has been conducted to date to establish the anticancer potential of BBR. The present review consolidates salient information concerning the promising anticancer activity of this compound. The therapeutic efficacy of BBR has been reported in several studies regarding colon, breast, pancreatic, liver, oral, bone, cutaneous, prostate, intestine, and thyroid cancers. BBR prevents cancer cell proliferation by inducing apoptosis and controlling the cell cycle as well as autophagy. BBR also hinders tumor cell invasion and metastasis by down-regulating metastasis-related proteins. Moreover, BBR is also beneficial in the early stages of cancer development by lowering epithelial–mesenchymal transition protein expression. Despite its significance as a potentially promising drug candidate, there are currently no pure berberine preparations approved to treat specific ailments. Hence, this review highlights our current comprehensive knowledge of sources, extraction methods, pharmacokinetic, and pharmacodynamic profiles of berberine, as well as the proposed mechanisms of action associated with its anticancer potential. The information presented here will help provide a baseline for researchers, scientists, and drug developers regarding the use of berberine as a promising candidate in treating different types of cancers.

13 June 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
MSMin Shi
Min Shi
JGJingyu Gu
Jingyu Gu
HWHanjing Wu
Hanjing Wu
Abdur RaufAbdur Rauf
Abdur Rauf
TETalha Bin Emran
Talha Bin Emran
Hafiz SuleriaHafiz Suleria
Hafiz Suleria
Lettuce is one of the most famous leafy vegetables worldwide with lots of applications from food to other specific uses. There are different types in the lettuce group for consumers to choose from. Additionally, lettuce is an excellent source of bioactive compounds such as polyphenols, carotenoids, and chlorophyll with related health benefits. At the same time, nutrient composition and antioxidant compounds are different between lettuce varieties, especially for green and red lettuce types. The benefit of lettuce consumption depends on its composition, particularly antioxidants, which can function as nutrients. The health benefits rely on their biochemical effect when reaching the bloodstream. Some components can be released from the food matrix and altered in the digestive system. Indeed, the bioaccessibility of lettuce is measuring the quantity of these compounds released from the food matrix during digestion, which is important for health-promoting features. Extraction of bioactive compounds is one of the new trends observed in lettuce and is necessarily used for several application fields. Therefore, this review aims to demonstrate the nutritional value of lettuce and its pharmacological properties. Due to their bioaccessibility and bioavailability, the consumer will be able to comprehensively understand choosing a healthier lettuce diet. The common utilization pattern of lettuce extracted nutrients will also be summarized for further direction.

1 December 2021 in Journal of Environmental Chemical Engineering
Verified
Journal Article
Closed access
SKSikandar Khan
Sikandar Khan
XCXiaojing Chen
Xiaojing Chen
AAAlbandary Almahri
Albandary Almahri
EAEsam S. Allehyani
Esam S. Allehyani
Fahad A. AlhumaydhiFahad A. Alhumaydhi
Fahad A. Alhumaydhi
Shujat AliShujat Ali
Shujat Ali

2 March 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MSMoyad Shahwan
Moyad Shahwan
Fahad A. AlhumaydhiFahad A. Alhumaydhi
Fahad A. Alhumaydhi
Ghulam M. AshrafGhulam M. Ashraf
Ghulam M. Ashraf
PHPrince M.Z. Hasan
Prince M.Z. Hasan
Anas ShamsiAnas Shamsi
Anas Shamsi